NCT06883656View on ClinicalTrials.gov

The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Type 2 Diabetes Mellitus (T2DM)Renal Insuficiency
Interventions
DRUG

SAL067

Fasting oral test drug 12mg

Trial Locations (1)

61000

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Shenzhen Salubris Pharmaceuticals Co., Ltd.

INDUSTRY